Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Chen, Wei  [Clear All Filters]
2024
Shi M, Wang J, Huang H, Liu D, Cheng H, Wang X, Chen W, Yan Z, Sang W, Qi K, et al. Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nat Commun. 2024;15(1):3371.
Lu W, Xi X, Jing Y, Si Y, Du Z, Wang Y, Chen W, Tang X. A Case of Female X-linked Chronic Granulomatous Disease Caused by X Chromosome Inactivation Treated with Hematopoietic Stem Cell Transplantation and Literature Review. Altern Ther Health Med. 2024.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, et al. Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy. Cytotherapy. 2024.
Chai M, Su G, Chen W, Gao J, Wu Q, Song J, Zhang Z. Effects of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes in Central Nervous System Diseases. Mol Neurobiol. 2024.
Xiao X, Gao Y, Yan L, Deng C, Wu W, Lu X, Lu Q, Zhong W, Xu Y, Zhang C, et al. M1 polarization of macrophages promotes stress-induced hair loss via interleukin-18 and interleukin-1β. J Cell Physiol. 2024.
Jiang P, Yang P, Wang W, Cao J, Chen W, Fu J, Lu L, Lu Y, Zhu X. Management of neurotoxicity syndrome complicated by autologous hematopoietic stem cell transplantation bridge to chimeric antigen receptor T-Cell therapy: A case report. Asia Pac J Oncol Nurs. 2024;11(3):100368.
Chen W, Ren Q, Zhou J, Liu W. Mesenchymal Stem Cell-Induced Neuroprotection in Pediatric Neurological Diseases: Recent Update of Underlying Mechanisms and Clinical Utility. Appl Biochem Biotechnol. 2024.
Tian Y, Chen W, Du G, Gao J, Zhao Y, Wang Z, Su M, Hu R, Han F. Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies. Biofabrication. 2024.
Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, Alvarez JF, Ma F, Galindo DCeja, Maroney SP, et al. Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction. Cardiovasc Res. 2024.
Dong H, He X, Zhang L, Chen W, Lin Y-C, Liu S-B, Wang H, Nguyen LXuan Truon, Li M, Zhu Y, et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024.
2023
Huang W, Xia D, Bi W, Lai X, Yu B, Chen W. Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics. Stem Cell Res Ther. 2023;14(1):293.
Xia J, Li H, Yan Z, Zhou D, Wang Y, Qi Y, Cao J, Li D, Cheng H, Sang W, et al. Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial. J Clin Oncol. 2023:JCO2201824.
Xu H, Zhu Y, Hsiao AWei-Ting, Xu J, Tong W, Chang L, Zhang X, Chen Y-F, Li J, Chen W, et al. Bioactive glass-elicited stem cell-derived extracellular vesicles regulate M2 macrophage polarization and angiogenesis to improve tendon regeneration and functional recovery. Biomaterials. 2023;294:121998.
Si Y, Luo R, Qin M, Du Z, Zhang X, Wang Y, Chen W, Gu W, Xing G, Dou L, et al. Busulfan for allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia: A retrospective study. Acta Haematol. 2023.
Liu Y, Jie X, Nian L, Wang Y, Wang C, Ma J, Jiang J, Wu Q, Qiao J, Chen W, et al. A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells. Front Immunol. 2023;14:1169071.
Huang F, Sun J, Chen W, Zhang L, He X, Dong H, Wu Y, Wang H, Li Z, Ball B, et al. Correction: TET2 deficiency promotes MDS-associated leukemogenesis. Blood Cancer J. 2023;13(1):174.
Du X, Fei X, Wang J, Dong Y, Fan L, Yang B, Chen W, Gong Y, Xia B, Zhu H, et al. Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer. Transl Oncol. 2023;34:101701.
Tan J, Chen M, Liu M, Chen A, Huang M, Chen X, Tian X, Chen W. Exosomal miR-192-5p secreted by bone marrow mesenchymal stem cells inhibits hepatic stellate cell activation and targets PPP2R3A. J Histotechnol. 2023:1-12.
Zhang Y, Liu FA, Liang XL, Zhu J, Han L, Shi XD, Cao J, Li Z, Chen W, Xu K, et al. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients. Clin Exp Med. 2023.
Liu M-J, Du B, Yu J-S, Zhao J, Chen H, Xiang X-S, Wang Y-Z, Chen W. Hsa_circ_0007334 Promotes the Osteogenic Differentiation and Proliferation of Human Bone Marrow Mesenchymal Stem Cells by Sponging miR-144-3p. Crit Rev Eukaryot Gene Expr. 2023;33(3):61-70.
Li X, Guo L, Chen J, Liang H, Liu Y, Chen W, Zhou L, Shan L, Wang H. Intravenous injection of human umbilical cord-derived mesenchymal stem cells ameliorates not only blood glucose but also nephrotic complication of diabetic rats through autophagy-mediated anti-senescent mechanism. Stem Cell Res Ther. 2023;14(1):146.
Zhang Y, Chen W, Dong X, Shang W, Shao S, Zhang L. Long-term maintenance of human endometrial epithelial organoids and their stem cell properties. Reprod Toxicol. 2023:108522.
Zhu W, Ou L, Zhang L, Clark IH, Zhang Y, Zhu X-H, Whitley CB, Hackett PB, Low WC, Chen W. Mapping brain networks in MPS I mice and their restoration following gene therapy. Sci Rep. 2023;13(1):12716.
Xu J, Li X, Chen W, Zhang Z, Zhou Y, Gou Y, Lv C-A, Jin L, Qiu X, Ma S, et al. Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. J Exp Med. 2023;220(9).
Wang P, Su J, Wang J, Xie Y, Chen W, Zhong J, Wang Y. NRF1 promotes primordial germ cell development, proliferation and survival. Cell Prolif. 2023:e13533.

Pages